LPS priming before plaque deposition impedes microglial activation and restrains Aß pathology in the 5xFAD mouse model of Alzheimer′s disease

被引:11
作者
Yang, Yiyi [1 ,5 ]
Garcia-Cruzado, Marta [1 ]
Zeng, Hairuo [1 ]
Camprubi-Ferrer, Lluis [1 ]
Bahatyrevich-Kharitonik, Bazhena [1 ,2 ,4 ]
Bachiller, Sara [1 ,2 ,3 ]
Deierborg, Tomas [1 ,5 ]
机构
[1] Lund Univ, Dept Expt Med Sci, Expt Neuroinflammat Lab, Lund, Sweden
[2] Univ Seville, Virgen del Rocio Univ Hosp, Inst Biomed Seville IBiS, CSIC, Seville, Spain
[3] Univ Seville, Sch Med, Dept Med Biochem Mol Biol & Immunol, Seville, Spain
[4] Univ Seville, Fac Pharm, Dept Biochem & Mol Biol, Seville, Spain
[5] Lund Univ, Expt Med Sci, Neuroinflammat, BMC B11,Solvegatan 19, S-22362 Lund, Sweden
基金
瑞典研究理事会;
关键词
LPS; Priming; Innate immune memory; Microglia; ss-amyloid pathology; Neuroinflammation; Long-term effects; Systemic inflammation; Proteomics; HIPPOCAMPAL NEUROGENESIS; NEUROTROPHIC FACTOR; PREFRONTAL CORTEX; PROGRESSION; TURNOVER; PROTEIN; MICE; NEURODEGENERATION; HYPERACTIVITY; INFLAMMATION;
D O I
10.1016/j.bbi.2023.07.006
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Microglia have an innate immunity memory (IIM) with divergent functions in different animal models of neurodegenerative diseases, including Alzheimer's disease (AD). AD is characterized by chronic neuroinflammation, neurodegeneration, tau tangles and ss-amyloid (A ss) deposition. Systemic inflammation has been implicated in contributing to the progression of AD. Multiple reports have demonstrated unique microglial signatures in AD mouse models and patients. However, the proteomic profiles of microglia modified by IIM have not been well-documented in an AD model. Therefore, in the present study, we investigate whether lipopolysaccharide (LPS)-induced IIM in the pre-clinical stage of AD alters the microglial responses and shapes the neuropathology. We accomplished this by priming 5xFAD and wild-type (WT) mice with an LPS injection at 6 weeks (before the robust development of plaques). 140 days later, we evaluated microglial morphology, activation, the microglial barrier around A ss, and A ss deposition in both 5xFAD primed and unprimed mice. Priming induced decreased soma size of microglia and reduced colocalization of PSD95 and Synaptophysin in the retrosplenial cortex. Priming appeared to increase phagocytosis of A ss, resulting in fewer Thioflavin S+ A ss fibrils in the dentate gyrus. RIPA-soluble A ss 40 and 42 were significantly reduced in Primed-5xFAD mice leading to a smaller size of MOAB2(+) A ss plaques in the prefrontal cortex. We also found that A ss-associated microglia in the Primed-5xFAD mice were less activated and fewer in number. After priming, we also observed improved memory performance in 5xFAD. To further elucidate the molecular mechanism underlying these changes, we performed quantitative proteomic analysis of microglia and bone marrow monocytes. A specific pattern in the microglial proteome was revealed in primed 5xFAD mice. These results suggest that the imprint signatures of primed microglia display a distinctive phenotype and highlight
引用
收藏
页码:228 / 247
页数:20
相关论文
共 50 条
  • [1] Innate immune alterations are elicited in microglial cells before plaque deposition in the Alzheimer's disease mouse model 5xFAD
    Boza-Serrano, Antonio
    Yang, Yiyi
    Paulus, Agnes
    Deierborg, Tomas
    SCIENTIFIC REPORTS, 2018, 8
  • [2] Tetrandrine ameliorated Alzheimer's disease through suppressing microglial inflammatory activation and neurotoxicity in the 5XFAD mouse
    Ren, Defang
    Fu, Yu
    Wang, Li
    Liu, Jianqin
    Zhong, Xia
    Yuan, Jiyuan
    Jiang, Chaoli
    Wang, Honglian
    Li, Zhi
    PHYTOMEDICINE, 2021, 90
  • [3] Temporal gene profiling of the 5XFAD transgenic mouse model highlights the importance of microglial activation in Alzheimer’s disease
    Véréna Landel
    Kévin Baranger
    Isabelle Virard
    Béatrice Loriod
    Michel Khrestchatisky
    Santiago Rivera
    Philippe Benech
    François Féron
    Molecular Neurodegeneration, 9
  • [4] Temporal gene profiling of the 5XFAD transgenic mouse model highlights the importance of microglial activation in Alzheimer's disease
    Landel, Verena
    Baranger, Kevin
    Virard, Isabelle
    Loriod, Beatrice
    Khrestchatisky, Michel
    Rivera, Santiago
    Benech, Philippe
    Feron, Francois
    MOLECULAR NEURODEGENERATION, 2014, 9
  • [5] Behaviour Hallmarks in Alzheimer's Disease 5xFAD Mouse Model
    Padua, Mafalda Soares
    Guil-Guerrero, Jose L.
    Lopes, Paula Alexandra
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (12)
  • [6] Temporal Pattern of Neuroinflammation Associated with a Low Glycemic Index Diet in the 5xFAD Mouse Model of Alzheimer's Disease
    Dafnis, Ioannis
    Mountaki, Christina
    Fanarioti, Eleni
    Mastellos, Dimitrios C.
    Karvelas, Michalis
    Karathanos, Vaios T.
    Tzinia, Athina
    Dermon, Catherine R.
    Chroni, Angeliki
    MOLECULAR NEUROBIOLOGY, 2022, 59 (12) : 7303 - 7322
  • [7] Systematic phenotyping and characterization of the 5xFAD mouse model of Alzheimer's disease
    Forner, Stefania
    Kawauchi, Shimako
    Balderrama-Gutierrez, Gabriela
    Kramar, Eniko A.
    Matheos, Dina P.
    Phan, Jimmy
    Javonillo, Dominic, I
    Tran, Kristine M.
    Hingco, Edna
    da Cunha, Celia
    Rezaie, Narges
    Alcantara, Joshua A.
    Baglietto-Vargas, David
    Jansen, Camden
    Neumann, Jonathan
    Wood, Marcelo A.
    MacGregor, Grant R.
    Mortazavi, Ali
    Tenner, Andrea J.
    LaFerla, Frank M.
    Green, Kim N.
    SCIENTIFIC DATA, 2021, 8 (01)
  • [8] Antenatal Hypoxia Accelerates the Onset of Alzheimer's Disease Pathology in 5xFAD Mouse Model
    Shen, Guofang
    Hu, Shirley
    Zhao, Zhen
    Zhang, Lubo
    Ma, Qingyi
    FRONTIERS IN AGING NEUROSCIENCE, 2020, 12
  • [9] Glial Gap Junction Pathology in the Spinal Cord of the 5xFAD Mouse Model of Early-Onset Alzheimer's Disease
    Pechlivanidou, Maria
    Kousiappa, Ioanna
    Angeli, Stella
    Sargiannidou, Irene
    Koupparis, Andreas M.
    Papacostas, Savvas S.
    Kleopa, Kleopas A.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (24)
  • [10] Synthetic PPAR Agonist DTMB Alleviates Alzheimer's Disease Pathology by Inhibition of Chronic Microglial Inflammation in 5xFAD Mice
    Oh, Eunji
    Kang, Jeong-Hwa
    Jo, Kyung Won
    Shin, Won-Sik
    Jeong, Young-Hun
    Kang, Byunghee
    Rho, Tae-Young
    Jeon, So Yeon
    Lee, Jihoon
    Song, Im-Sook
    Kim, Kyong-Tai
    NEUROTHERAPEUTICS, 2022, 19 (05) : 1546 - 1565